Table 2. Nephridial SOD (U mg–1 protein), CAT (U mg–1 protein), GSH-Px (U L–1 protein) and GSH (mg GSH g–1 protein) levels and nephridial MDA (nmol mL–1) concentrations.
| Groups | SOD (U mg–1) | CAT (U mg–1) | GSH-PX (U L–1) | GSH (mg g–1) | MDA (nmol mL–1) |
| Normal control | 49.46 ± 0.18 b | 78.22 ± 0.13 b | 892.44 ± 16.32 b | 5.42 ± 0.24 b | 2.84 ± 0.21 b |
| Model control | 30.45 ±1.12 | 44.13 ± 1.25 | 688.45 ± 12.67 | 3.05 ± 0.11 | 5.05 ± 0.15 |
| Positive control (HC) | 45.61 ± 0.75 b | 70.52 ± 0.46 b | 842.21 ± 13.38 b | 4.98 ± 0.62 b | 3.07 ± 0.68 b |
| Low dose LIM | 32.32 ± 4.02 a | 60.53 ± 0.14 b | 743.09 ± 11.42 b | 4.19 ± 0.26 b | 3.95 ± 0.38 b |
| High dose LIM | 38.25 ± 1.24 b | 64.45 ± 0.98 b | 790.43 ± 13.68 b | 4.84 ± 0.26 b | 3.74 ± 0.45 b |
| Low dose LIM + HC | 46.52 ± 5.96 b | 74.25 ± 1.12 b | 850.44 ± 12.32 b | 5.23 ± 0.34 b | 3.05 ± 0.11 b |
| High dose LIM + HC | 48.58 ± 2.50 b | 76.47 ± 1.34 b | 878.91 ± 12.43 b | 5.38 ± 0.27 b | 2.88 ± 0.35 b |
a p < 0.05, significantly different from model control group.
b p < 0.01, highly significantly different from model control group. The mice in each group were ten.